Aptevo Therapeutics
APVO
1 hedge funds and large institutions have $65.5M invested in Aptevo Therapeutics in 2021 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 1 → 1 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% less ownership
Funds ownership: 0% → 0% (-0%)
27% less capital invested
Capital invested by funds: $89.7M → $65.5M (-$24.2M)
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GTC
Ghost Tree Capital
New York
|
-$1.53M |
| 2 |
Two Sigma Investments
New York
|
-$1.21M |
| 3 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$1.18M |
| 4 |
Two Sigma Advisers
New York
|
-$928K |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$674K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
26
Bank of Montreal
Toronto,
Ontario, Canada
| – | -$674K | – | – |
|
27
Bank of New York Mellon
New York
| – | -$305K | – | – |
|
|
GTC
28
Ghost Tree Capital
New York
| – | -$1.53M | – | – |
|
29
Marshall Wace
London,
United Kingdom
| – | -$244K | – | – |
|
|
SSA
30
Schonfeld Strategic Advisors
New York
| – | -$296K | – | – |
|
|
SFS
31
Sowell Financial Services
North Little Rock,
Arkansas
| – | -$1K | – | – |
|
|
SCM
32
Stonepine Capital Management
Bend,
Oregon
| – | -$1.18M | – | – |
|
|
TRSOTSOK
33
Teachers Retirement System of the State of Kentucky
Frankfort,
Kentucky
| – | -$12K | – | – |
|
|
TRCT
34
Tower Research Capital (TRC)
New York
| – | -$4K | – | – |
|
|
35
Two Sigma Advisers
New York
| – | -$928K | – | – |
|
|
36
Two Sigma Investments
New York
| – | -$1.21M | – | – |
|
APVO Hedge Fund Activity: Q2 2021 in Review
1 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Aptevo Therapeutics (APVO) for Q2 2021, worth a combined $65.5M — down 27% from $89.7M a quarter earlier.
Fund positioning in APVO was balanced in Q2 2021: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.
The largest seller was Ghost Tree Capital, cutting an estimated $1.53M.
- 1 institutional investor held Aptevo Therapeutics (APVO) as of Q2 2021, unchanged from Q1 2021.
- Funds reported $65.5M of Aptevo Therapeutics stock for Q2 2021, down 27% quarter-over-quarter.
- 0 funds opened new Aptevo Therapeutics positions in Q2 2021 and 0 closed out.
- The largest Aptevo Therapeutics seller in Q2 2021 was Ghost Tree Capital, an estimated $1.53M sold.
Based on aggregated 13F filings for Q2 2021.